CytomX Therapeutics (CTMX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

CTMX is expected to report earnings to rise 102.88% to -16 cents per share on November 07

CytomX Therapeutics CTMX Stock Earnings Reports

Q3'24

Est.

$-0.16

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.25

Q4'23

Missed

by $0.03

Q3'23

Beat

by $0.23

The last earnings report on August 08 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 974.74K shares outstanding, the current market capitalization sits at 93.74M.

View a ticker or compare two or three

Compare

CTMX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CTMX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

151 Oyster Point Boulevard

Phone

+1 650 515-3185

Employees

122

Web

https://www.cytomx.com